Fox Run Management L.L.C. grew its stake in Centene Corporation (NYSE:CNC – Free Report) by 43.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,290 shares of the company’s stock after acquiring an additional 4,902 shares during the period. Fox Run Management L.L.C.’s holdings in Centene were worth $884,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Polianta Ltd bought a new position in shares of Centene in the 2nd quarter valued at $1,253,000. Oliver Luxxe Assets LLC bought a new position in Centene in the second quarter valued at about $4,033,000. Focus Partners Wealth boosted its stake in shares of Centene by 83.1% during the first quarter. Focus Partners Wealth now owns 42,270 shares of the company’s stock valued at $2,566,000 after purchasing an additional 19,181 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Centene by 3.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,810,489 shares of the company’s stock valued at $292,045,000 after buying an additional 143,573 shares during the period. Finally, Focused Investors LLC raised its holdings in Centene by 19.9% in the 2nd quarter. Focused Investors LLC now owns 1,250,000 shares of the company’s stock valued at $67,850,000 after buying an additional 207,600 shares during the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Stock Performance
Shares of CNC opened at $37.49 on Monday. Centene Corporation has a one year low of $25.08 and a one year high of $66.81. The firm has a market capitalization of $18.43 billion, a PE ratio of -3.46, a price-to-earnings-growth ratio of 1.24 and a beta of 0.49. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.08 and a quick ratio of 1.10. The company has a 50-day simple moving average of $34.33 and a two-hundred day simple moving average of $40.60.
Wall Street Analysts Forecast Growth
CNC has been the topic of a number of research reports. Robert W. Baird reduced their target price on shares of Centene from $68.00 to $28.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Barclays set a $44.00 target price on shares of Centene and gave the company an “equal weight” rating in a research report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Centene from $24.00 to $32.00 in a report on Friday, October 31st. Truist Financial reiterated a “buy” rating and set a $45.00 price target (up previously from $42.00) on shares of Centene in a report on Thursday, October 30th. Finally, Wells Fargo & Company set a $41.00 price target on Centene and gave the company an “equal weight” rating in a research report on Tuesday, October 7th. Three investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $39.82.
Check Out Our Latest Stock Report on Centene
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Further Reading
- Five stocks we like better than Centene
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
